Na. Dezutter et al., In vitro affinity of Tc-99(m)-labelled N2S2 conjugates of chrysamine G foramyloid deposits of systemic amyloidosis, NUCL MED C, 22(5), 2001, pp. 553-558
To date, systemic amyloidosis is diagnosed histologically in vitro using Co
ngo red staining or in vivo using iodine-123 serum amyloid P component (I-1
23-SAP) scintigraphy. Tc-99(m)-labelled derivatives of chrysamine G (CG), a
Lipophilic analogue of Congo red, were synthesized as potential tracer age
nts for direct and quantitative scintigraphic evaluation of amyloid deposit
s. To determine the affinity of Tc-99(m)-MAMA-CG, Tc-99(m)-Me(4)MAMA-CG and
Tc-99(m)-MAMA-CG diethyl ester for amyloid, in vitro autoradiography was p
erformed on sections of human kidney biopsy cylinders from kidneys with amy
loid deposits (types AA, A lambda and A kappa) or control kidney tissue aft
er incubation with the respective tracer agents. The binding of Tc-99(m)-MA
MA-CG and its tetramethyl derivative was higher to kidney biopsy material w
ith amyloid deposits of the AA, A lambda, or A kappa type compared with con
trol kidney tissue. This higher binding was prevented by the presence of 10
muM Congo red in the incubation medium. The diethyl ester of Tc-99(m)-MAMA
-CG did not demonstrate increased binding to Congo red-positive kidney tiss
ue. In conclusion, Tc-99(m)-MAMA-CG and Tc-99(m)-Me(4)MAMA-CG localize spec
ifically to amyloid deposits in human kidney tissue, suggesting that these
tracer agents may be applicable as specific targeting agents for diagnostic
purposes in clinical amyloidosis. ((C) 2001 Lippincott Williams & Wilkins)
.